Torres S. Edward

CIK 00015522936 companiesSAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001552293

Recent Transactions

50 trades

Conversion
Surface Oncology, Inc.
Series A Preferred Stock
2018-04-23−7,000,000→ 0 total
Conversion
Surface Oncology, Inc.
Common Stock
2018-04-23+3,181,817→ 3,181,817 total
Purchase
Surface Oncology, Inc.
Common Stock
2018-04-23$15.00/sh+266,000→ 3,447,817 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series E-2 Preferred Stock
2017-07-05−1,907,373→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05+844,987→ 844,987 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series E-3 Preferred Stock
2017-07-05−1,654,411→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series D Preferred Stock
2017-07-05−3,390,885→ 0 total
Conversion
Rein Therapeutics, Inc.$RNTX
Series F Preferred Stock
2017-07-05−1,443,972→ 0 total
Purchase
Rein Therapeutics, Inc.$RNTX
Common Stock
2017-07-05$15.00/sh+250,000→ 1,094,987 total
Conversion
Protagonist Therapeutics, Inc$PTGX
Series B Preferred Stock
2016-08-16−9,142,857→ 0 total
Conversion
Protagonist Therapeutics, Inc$PTGX
Series A Preferred Stock
2016-08-16−3,000,000→ 0 total
Conversion
Protagonist Therapeutics, Inc$PTGX
Series C Preferred Stock
2016-08-16−9,841,333→ 0 total
Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2016-08-16+206,896→ 206,896 total
Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2016-08-16+678,712→ 1,516,149 total
Conversion
Protagonist Therapeutics, Inc$PTGX
Common Stock
2016-08-16+630,541→ 837,437 total
Purchase
Protagonist Therapeutics, Inc$PTGX
Common Stock
2016-08-16$12.00/sh+583,333→ 2,099,482 total
Sale
GLOBEIMMUNE INC
Common Stock
2016-03-17$1.67/sh−26,188→ 241,706 total
Disposition to Issuer
Receptos, Inc.
Stock Option (right to buy)
2015-08-27$213.23/sh−18,800→ 0 total
Disposition to Issuer
Receptos, Inc.
Common Stock
2015-08-27−7,400→ 0 total
Disposition to Issuer
Receptos, Inc.
Stock Option (right to buy)
2015-08-27$204.56/sh−9,400→ 0 total
Disposition from Tender
Receptos, Inc.
Common Stock
2015-08-25−665,561→ 0 total
Award
GLOBEIMMUNE INC
Stock Option (right to buy)
2015-07-09+1,697→ 1,697 total
Sale
Receptos, Inc.
Common Stock
2015-06-16$182.89/sh−50,400→ 665,561 total
Sale
Receptos, Inc.
Common Stock
2015-06-15$175.54/sh−88,400→ 715,961 total
Sale
Receptos, Inc.
Common Stock
2015-06-12$180.33/sh−81,200→ 804,361 total
Award
Receptos, Inc.
Common Stock
2015-05-28+7,400→ 7,400 total
Sale
Receptos, Inc.
Common Stock
2015-02-27$130.15/sh−7,200→ 885,561 total
Sale
Receptos, Inc.
Common Stock
2015-02-23$130.54/sh−25,953→ 919,161 total
Sale
Receptos, Inc.
Common Stock
2015-02-23$129.95/sh−26,400→ 892,761 total
Sale
Receptos, Inc.
Common Stock
2015-02-20$125.43/sh−21,953→ 945,114 total
Sale
Receptos, Inc.
Common Stock
2014-09-23$61.07/sh−85,682→ 967,067 total
Sale
Receptos, Inc.
Common Stock
2014-09-22$63.08/sh−14,318→ 1,052,749 total
Sale
Receptos, Inc.
Common Stock
2014-09-19$62.55/sh−169,570→ 1,067,067 total
Sale
Receptos, Inc.
Common Stock
2014-09-18$62.77/sh−91,513→ 1,236,637 total
Sale
Receptos, Inc.
Common Stock
2014-09-17$63.67/sh−38,917→ 1,328,150 total
Sale
Receptos, Inc.
Common Stock
2014-08-13$43.24/sh−200,000→ 1,367,067 total
Conversion
GLOBEIMMUNE INC
Series B Convertible Preferred Stock
2014-07-08−3,736,921→ 0 total
Conversion
GLOBEIMMUNE INC
Series C Convertible Preferred Stock
2014-07-08−1,685,796→ 0 total
Conversion
GLOBEIMMUNE INC
Warrant to Purchase Common Stock (right to buy)
2014-07-08+1,614→ 1,614 total
Conversion
GLOBEIMMUNE INC
Warrant to Purchase Series C Preferred Stock (right to buy)
2014-07-08$1.45/sh−50,684→ 0 total
Conversion
GLOBEIMMUNE INC
Warrant to Purchase Common Stock (right to buy)
2014-07-08+1,614→ 1,614 total
Conversion
GLOBEIMMUNE INC
Series E Convertible Preferred Stock
2014-07-08−318,411→ 0 total
Conversion
GLOBEIMMUNE INC
Common Stock
2014-07-08+182,894→ 182,894 total
Purchase
GLOBEIMMUNE INC
Common Stock
2014-07-08$10.00/sh+85,000→ 267,894 total
Award
Receptos, Inc.
Stock Option (right to buy)
2013-07-17+18,800→ 18,800 total
Conversion
Receptos, Inc.
Common Stock
2013-05-14$7.73/sh+672,029→ 1,938,353 total
Conversion
Receptos, Inc.
Common Stock
2013-05-14$5.25/sh+1,152,039→ 1,266,324 total
Purchase
Receptos, Inc.
Common Stock
2013-05-14$14.00/sh+142,857→ 2,081,210 total
Conversion
Receptos, Inc.
Series A Preferred Stock
2013-05-14→ 0 total
Conversion
Receptos, Inc.
Series B Preferred Stock
2013-05-14→ 0 total

Companies

Recent Filings

Address

10835 ROAD TO THE CURE, SUITE 205

SAN DIEGO, CA, 92121

View on SEC.gov